BRIEF published on 06/21/2024 at 17:39, 5 months 2 days ago Travis Perkins: Notification of Change in Voting Rights Voting Rights Financial Announcement Shareholding Travis Perkins Artemis Investment Management
PRESS RELEASE published on 06/21/2024 at 17:34, 5 months 2 days ago Travis Perkins: Notification of change in voting rights Travis Perkins PLC discloses change in voting rights as Artemis Investment Management LLP crosses threshold on 20-Jun-2024 Voting Rights Major Holdings Notification Travis Perkins Plc Artemis Investment Management LLP
BRIEF published on 06/21/2024 at 08:05, 5 months 2 days ago Travis Perkins Announces RBC Capital Markets as Joint Corporate Broker Construction Industry Citi Travis Perkins Corporate Broker RBC Capital Markets
PRESS RELEASE published on 06/21/2024 at 08:00, 5 months 2 days ago Travis Perkins: Appointment of joint corporate broker Travis Perkins plc appoints RBC Capital Markets as Joint Corporate Broker alongside Citi, enhancing their investor relations strategy Construction Industry Investor Relations Travis Perkins Plc RBC Capital Markets Joint Corporate Broker
BRIEF published on 06/11/2024 at 18:04, 5 months 12 days ago Travis Perkins: Director Nick Roberts Acquires Shares Market Abuse Regulation Share Purchase Travis Perkins Nick Roberts BAYE Scheme
PRESS RELEASE published on 06/11/2024 at 17:59, 5 months 12 days ago Travis Perkins: Director/PDMR Shareholding Travis Perkins (TPK) announces Director/PDMR Shareholding. Nick Roberts purchased 18 ordinary shares under the BAYE scheme. Notification complies with UK Market Abuse Regulation PDMR Shareholding Travis Perkins BAYE Scheme Director
BRIEF published on 05/16/2024 at 18:15, 6 months 7 days ago Travis Perkins Announces Major Shareholding Update Shareholding Travis Perkins Financial Instruments Bank Of America TR1 Notification
PRESS RELEASE published on 05/16/2024 at 18:10, 6 months 7 days ago Travis Perkins: TR1 Notification of Major Share Interest Bank of America Corporation notifies Travis Perkins PLC of updated cash equity positions, resulting in 1.888432% of voting rights on 14-May-2024 Voting Rights Travis Perkins TPK Bank Of America Corporation Notification Of Major Share Interest
BRIEF published on 05/13/2024 at 17:00, 6 months 10 days ago Travis Perkins Reports Director/PDMR's Share Purchase Under Dividend Re-investment Plan Market Abuse Regulation Travis Perkins PDMR Shareholding Stock Transaction Dividend Re-investment Plan
PRESS RELEASE published on 05/13/2024 at 16:55, 6 months 10 days ago Travis Perkins: Director/PDMR Shareholding Travis Perkins (TPK) director and PDMR Rosamund Roberts purchases 649 ordinary shares at £7.98 each, complying with the Dividend Re-investment Plan Shareholding Travis Perkins TPK Dividend Re-investment Plan Rosamund Roberts
Published on 11/22/2024 at 23:55, 1 day 4 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 4 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 5 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 5 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 10 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 10 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 11 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 2 days 21 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 8 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 10 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 10 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024